With the start of a new week comes the excitement surrounding a new set of companies looking to make an impact through their public offerings. According to Benzinga Pro, these enticing companies are scheduled to trade publicly this week.
Chromocell Therapeutics Corporation (NYSE:CHRO) ("Chromocell" or the "Company"), a clinical-stage biotech company focused on developing and commercializing new, non-opioid therapeutics to alleviate pain, today announced
Editor's Note: This article has been updated to reflect that Flewber Global Inc is expected to IPO on February 16 under the ticker FLAI. A previous iteration of this article stated that the company would go IPO on February 15 under the ticker FLYF.
Sony Group Corp (NYSE: SONY) reported 22% sales growth in Q3 FY23, beating consensus. Adjusted EPS of $1.99 also beat expectations. Playstation 5 sales lowered to 21 million units, while financial arm to be listed in Oct 2025.
With the start of a new week comes the excitement surrounding a new set of companies looking to make an impact through their public offerings. According to Benzinga Pro, these enticing companies are scheduled to trade publicly this week.